OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
Richard B. Warren, Lars E. French, Andrew Blauvelt, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 3, pp. 494-503
Open Access | Times Cited: 12
Richard B. Warren, Lars E. French, Andrew Blauvelt, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 3, pp. 494-503
Open Access | Times Cited: 12
Showing 12 citing articles:
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents
Anastasia Drakos, Tiago Torres, Ronald Vender
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 111-111
Open Access | Times Cited: 11
Anastasia Drakos, Tiago Torres, Ronald Vender
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 111-111
Open Access | Times Cited: 11
Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 91-91
Open Access | Times Cited: 1
Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 91-91
Open Access | Times Cited: 1
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
Andrew Blauvelt, Richard Langley, Kenneth B. Gordon, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 12, pp. 3031-3042
Open Access | Times Cited: 17
Andrew Blauvelt, Richard Langley, Kenneth B. Gordon, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 12, pp. 3031-3042
Open Access | Times Cited: 17
Innovative Approaches to Psoriasis: Small Molecules Targeting Key Signaling Pathways
Meeral Gosia, Gaurav Doshi, Siddhi Bagwe Parab, et al.
Immunological Investigations (2025), pp. 1-37
Closed Access
Meeral Gosia, Gaurav Doshi, Siddhi Bagwe Parab, et al.
Immunological Investigations (2025), pp. 1-37
Closed Access
Moracin M derivative targeting PDE4 for the treatment of psoriasis
Liru Chen, Deyan Wu, Sen Wang, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 2
Open Access
Liru Chen, Deyan Wu, Sen Wang, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 2
Open Access
Advances in genetic–immunological targeted therapies for psoriasis
Zhen Qi, Yirui Wang, Zhuo Li, et al.
Current Opinion in Immunology (2025) Vol. 94, pp. 102559-102559
Closed Access
Zhen Qi, Yirui Wang, Zhuo Li, et al.
Current Opinion in Immunology (2025) Vol. 94, pp. 102559-102559
Closed Access
PDE4 inhibitors in psoriasis therapy: current insights and future directions
Amit Sharma, Niyati Pandoh, Keerti Dayal, et al.
Inflammopharmacology (2025)
Closed Access
Amit Sharma, Niyati Pandoh, Keerti Dayal, et al.
Inflammopharmacology (2025)
Closed Access
New and emerging oral therapies for psoriasis
Orhan Yılmaz, João Pedro Pinto, Tiago Torres
Drugs in Context (2024) Vol. 13, pp. 1-24
Open Access | Times Cited: 3
Orhan Yılmaz, João Pedro Pinto, Tiago Torres
Drugs in Context (2024) Vol. 13, pp. 1-24
Open Access | Times Cited: 3
Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasis
Gang Li, Dengqin He, Xudong Qian, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116930-116930
Closed Access | Times Cited: 2
Gang Li, Dengqin He, Xudong Qian, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116930-116930
Closed Access | Times Cited: 2
Innovations in Psoriasis
Amylee Martin, Marina Kristy Ibraheim, Rohit Gupta, et al.
Dermatologic Clinics (2024) Vol. 43, Iss. 1, pp. 1-9
Closed Access | Times Cited: 1
Amylee Martin, Marina Kristy Ibraheim, Rohit Gupta, et al.
Dermatologic Clinics (2024) Vol. 43, Iss. 1, pp. 1-9
Closed Access | Times Cited: 1
Phosphodiesterase 2 (PDE2) inhibitors: an updated patent review (2017–present)
Bei Zhang, Mei-Yan Jiang, Weihao Luo, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 11, pp. 1105-1119
Closed Access | Times Cited: 1
Bei Zhang, Mei-Yan Jiang, Weihao Luo, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 11, pp. 1105-1119
Closed Access | Times Cited: 1
Design, Synthesis, and Biological Evaluation of New Selective PDE4 Inhibitors for Topical Treatment of Psoriasis
Dengqin He, Gang Li, Jia‐Qiang Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20353-20371
Closed Access | Times Cited: 1
Dengqin He, Gang Li, Jia‐Qiang Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20353-20371
Closed Access | Times Cited: 1
Quoi de neuf en thérapeutique dermatologique ?
C. Paul
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S45-8S54
Closed Access
C. Paul
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S45-8S54
Closed Access
